Industry Updates

India-EU Free Trade Agreement marks a major shift for pharmaceuticals and medical devices, reshaping trade flows, tariff structures, and long-term MedTech collaboration between India and...

New solution establishes a governed integration engine to accelerate data exchange between Health Plans and Epic Payer Platform InterSystems, a creative data technology provider powering more...

Modern pharmaceutical manufacturing requires a shift from reactive problem-solving to proactive risk mitigation through structured frameworks that ensure patient safety and product efficacy across the global supply chain.

The strategic application of performance indicators allows healthcare leaders to move beyond intuitive management, leveraging objective data to enhance patient outcomes and operational sustainability across complex medical institutions.

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

Tempus and NYU Langone Health have signed a multi-year strategic collaboration to drive precision oncology using molecular profiling and data-driven research. The Tempus-NYU Langone collaboration...